Apop Imaging is a biotechnology startup that aims to revolutionize the healthcare field by pioneering advanced imaging, diagnostic, and therapeutic solutions. Founded in 2016, the company is focused on leveraging its proprietary calcitonin receptor antibody technology to develop and commercialize novel tools that enhance patient outcomes. Apop Imaging recently secured an Angel Round investment from Melbourne Angels in June 2018.
No recent news or press coverage available for Apop Imaging.